Summit Therapeutics Inc. Deferred Income Classified As Noncurrent
Summit Therapeutics Inc. (SMMT) had Deferred Income Classified As Noncurrent of GBP 1.08 million as of 2018-07-31, per its 6-K filed 2018-09-20.
Discontinued › Notes
ifrs-full:DeferredIncomeClassifiedAsNoncurrent · last filed 2018-09-20
- 2018-07-31: Deferred Income Classified As Noncurrent 1.08M GBP.
- 2018-04-30: Deferred Income Classified As Noncurrent 25.58M GBP.
- 2018-01-31: Deferred Income Classified As Noncurrent 27.27M GBP; Deferred Income Classified As Noncurrent as first filed 18.03M GBP.
- 2017-01-31: Deferred Income Classified As Noncurrent 23.61M GBP.
| Period end | Deferred Income Classified As Noncurrent | Deferred Income Classified As Noncurrent as first filed |
|---|---|---|
| 2018-07-31 | 1.08M GBP 6-K · filed 2018-09-20 | |
| 2018-04-30 | 25.58M GBP 6-K · filed 2018-06-05 | |
| 2018-01-31 | 27.27M GBP 6-K · filed 2018-09-20 | 18.03M GBP 20-F · filed 2018-04-13 |
| 2017-01-31 | 23.61M GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |